Company
Banking & finance
BPO
Compliance
Healthcare
Healthcare conferences often focus on breakthrough technologies, new devices or clinical innovation. WHX Dubai showed something slightly different. The most interesting discussions were not about what medicine can do, but about how healthcare is delivered — and why service design is becoming as important as medical capability.
Across multiple sessions one theme kept returning: healthcare is changing operationally. And once operations change, communication and customer experience change with it.
Technology to support clinicians
Healthcare technology is increasingly being designed to support patients and protect the operational capacity of medical staff. A growing share of healthcare innovation is aimed directly at clinicians — in practice, many new solutions function primarily as staff tools.
Today clinicians spend a significant portion of their working time on administrative and repetitive activities: searching for procedures, coordinating schedules, documenting visits, checking inventory or resolving operational issues. This workload affects efficiency but also fatigue and cognitive overload, which can ultimately influence the quality of care.
Monika Röhr-Łukasik Head of Advisory & International Growth, AxendiTechnology and AI are enablers, not replacements. Their role is to simplify and support the work of doctors and nurses who often make life-or-death decisions within seconds. The responsibility they carry is enormous, and innovation should strengthen their capacity and keep care close to the human behind it.
The solutions presented during the sessions reflected a broader operational shift rather than a collection of isolated tools. Hospitals and healthcare providers are implementing technologies that support the daily functioning of clinical teams and help preserve their ability to work effectively.
Examples included internal chat assistants that allow staff to quickly retrieve procedures, protocols and operational guidance, systems supporting task coordination and documentation, and digital assistants organizing the working day. Additional platforms addressed inventory control and risk management, while connected medical devices automatically transferred patient data into hospital systems, eliminating the need for manual entry.
From tools to ecosystems
A recurring theme across the discussions was that healthcare is no longer adopting technology as a set of separate solutions. The sector is transitioning toward workflow-oriented ecosystems, where multiple functions operate within one connected operational environment.
Instead of standalone applications, providers are implementing integrated platforms. Communication is embedded directly into clinical workflows, and information flows in real time between devices, staff and systems. The focus is on coordinating the entire care process.
The model is built around several operational pillars: connected medical devices, integrated communication channels, centralized data access and coordinated workflows across teams and departments. In this structure, technology stops being a supportive layer. It becomes part of everyday operations.
Operational implication for CX
This transformation has clear consequences for customer experience. Easier access to information, reduced documentation burden, fewer repetitive tasks and lower operational stress all directly affect service quality.
Patient experience is strongly linked to staff cognitive load. When clinicians must search for information, repeat administrative steps or manage fragmented systems, communication quality declines. When workflows are coordinated and information is readily available, interactions become more attentive, understandable and reassuring for patients.
Healthcare solutions expand market-by-market
Another important observation is that healthcare innovation does not scale globally in a uniform manner. New services and platforms are rarely launched simultaneously across countries because each market operates within a distinct healthcare context.
Differences appear at multiple levels: the structure of the healthcare system, reimbursement and insurance mechanisms, regulatory requirements, the digital maturity of providers, and patient behavior and expectations. As a result, companies introducing new healthcare services rarely pursue a single expansion model.
Instead, they enter selected markets gradually, reposition the same product locally, adapt operational workflows and onboarding processes, and redesign communication to reflect how care is actually delivered in a given country.
CX implication
In this environment, customer experience becomes part of implementation rather than a post-launch activity. Localization must go beyond translation and incorporate healthcare processes and system logic. Effective onboarding, patient education and country-specific knowledge bases are essential for adoption, because they reduce uncertainty and help users understand how the service works within their everyday care pathway.
AI optimizing hospital flow
Artificial intelligence in healthcare is often associated with diagnostics and clinical decision support, yet one of its fastest-growing applications is operational management. Hospitals are increasingly using AI to coordinate how care is delivered, not only how it is medically evaluated.
Typical use cases include predicting surgical duration, optimizing operating room schedules, coordinating staff availability and dynamically managing appointment calendars. Traditionally, hospital planning has relied on average procedure times. In reality, care pathways vary significantly, and even small deviations create cascading delays throughout the day.
By analyzing historical clinical and operational data, AI systems can estimate more realistic procedure durations and adjust schedules accordingly. This improves operational predictability and reduces bottlenecks across the patient journey.
The operational effects are tangible: waiting times shorten, appointments are rescheduled less frequently and the number of status-check calls from patients and families decreases. A key insight from the sessions was that many contacts are not driven by medical questions but by operational uncertainty — patients often call simply because they do not know whether everything is proceeding as planned.
CX implications
From a customer experience perspective, contact volume and contact type are often linked more to transparency than to service complexity. When operations are unpredictable, communication demand increases. Improving operational predictability does not eliminate customer service interactions, but it changes their character — shifting communication away from reassurance and status checking toward guidance and support throughout the care process.
From treatment to prevention — the longevity healthcare model
A broader systemic shift discussed across the conference concerns the very logic of healthcare delivery. The sector is gradually moving away from episodic, symptom-driven treatment toward continuous care focused on prevention and long-term health management.
In the traditional model, care follows a familiar sequence: symptoms appear, the patient schedules a visit, receives a diagnosis and undergoes treatment.
The emerging model functions differently. Continuous data collection enables screening and early risk detection, followed by targeted intervention and ongoing monitoring.
This approach relies on several interconnected elements: genetic and pharmacogenomic screening, epigenetic testing, continuous health monitoring through connected devices, preventive programs, lifestyle interventions and community-based health initiatives. Screening increasingly becomes the starting point of care rather than a supplementary service.
Monika Röhr-Łukasik Head of Advisory & International Growth, AxendiHealthcare is, above all, about human value. Whether we speak about prevention or treatment, meaningful and value-driven interaction remains at the core of care. Treating illness is costly, financially and emotionally, which is why prevention must become a priority. But prevention requires more than technology; it requires a change of mindset, investment, education and long-term thinking. The sector understands this. The real question is how quickly we can adapt.
Regulations needed
It is important to emphasize that healthcare innovation cannot function like consumer technology. New solutions must operate within strict regulatory frameworks and be supported by scientific validation and clinical evidence. Adoption depends not only on usability or technological sophistication but on demonstrated safety, medical credibility and compliance with national healthcare regulations.
Without regulatory approval, validated datasets and clinical proof of effectiveness, even the most advanced solution will not be integrated into real care pathways.
Daniel Stańczuk Site Director, AxendiIn the longevity model, the boundary between patient and customer begins to blur. Healthcare stops being a reactive intervention and becomes a continuous service focused on biological optimization. For customer experience, this represents a fundamental shift: we are closing the era of the issue resolution and entering the era of the health potential management.
CX implication
This transformation fundamentally alters the nature of patient interaction. Contact with healthcare organizations becomes ongoing rather than occasional.
Providers must now support patients in onboarding to preventive programs, interpreting test results, receiving reassurance when risk indicators appear and maintaining behavioral change over time. Engagement and guidance become as important as diagnosis.
Daniel Stańczuk Site Director, AxendiWithin longevity care, CX increasingly revolves around filtering the informational noise generated by wearables and genetic testing. Support is no longer simply a service desk; it evolves into a health navigator role. The key CX challenge becomes ongoing engagement behavior — how communication and data can sustain patient motivation for proactive action over decades, not only in moments of illness. This marks a move away from KPIs based on response time toward KPIs based on long-term wellbeing and healthspan.
Healthcare therefore shifts from case handling to relationship management, and customer experience becomes embedded in the care pathway itself rather than surrounding it.
Women’s health and fertility (FemTech)
Women’s health is increasingly emerging as a distinct segment within healthcare, particularly in areas such as fertility and hormonal health. A noticeable change is the relocation of certain services from clinics into the home environment.
New solutions now enable virtual health assessments, at-home hormone testing, cycle and ovulation prediction and clinician-supported remote monitoring. The model shifts from clinic-based diagnosis toward early detection, guidance and ongoing observation. For many women, time constraints and caregiving responsibilities delay medical visits, so home testing significantly improves accessibility.
Artificial intelligence plays an important role by analyzing symptom patterns, hormone measurements and calculated risk scores. Because women’s health has historically been under-researched, specialized datasets are necessary to interpret results correctly. Clinicians remain part of the process — technology does not replace them but helps determine when medical consultation becomes necessary.
Daniel Stańczuk Site Director, AxendiTreating women as a distinct, strategic target group is not “pink marketing”; it is a correction of a historical medical bias. In women’s patient support, an emerging concept is validation as a service. For years, women’s symptoms were often minimized or dismissed (so-called medical gaslighting), which means that modern support systems must be built on deep empathy supported by credible data.
An important point raised during discussions was that many women seek confirmation before a formal diagnosis. They often sense that something is wrong and are looking for validation and direction. As a result, providers increasingly rely on patient-reported data and build services that acknowledge and trust these inputs.
FemTech journeys are therefore characterized by frequent interactions, higher emotional sensitivity and a strong need for reassurance.
CX implication
In this model, support is not an activity that follows treatment; it becomes part of care itself. Organizations must provide structured onboarding and education, clear explanation of results, reassurance and emotional support, next-step guidance and escalation paths to clinicians when needed. In women’s health services, patient support is also increasingly designed around biological cycles, adapting communication, monitoring and recommendations to hormonal phases and changing symptoms over time.
Experience and trust directly determine adoption and retention. The quality of communication often influences not only satisfaction but whether the medical service or product is used at all.
Axendi works with healthcare organizations that run preventive programs, for example by introducing specialized diagnostic screening packages focused on women’s health. We support these initiatives through informational campaigns conducted by our consultants and by incorporating appropriate messaging into the IVR.
Daniel Stańczuk Site Director, AxendiIf women become the primary decision-makers in their care, CX must account for cyclicality — not only fertility, but the full hormonal spectrum influencing metabolism, sleep and mental health. Support in FemTech is therefore evolving toward a model of shared decision-making. This is no longer a structure in which the doctor speaks and the patient listens. Instead, technology provides women with evidence (biomarkers), while support helps them act as the “chief medical officer” of their own lives and families. In this context, trust is built not through speed of response, but through the quality of understanding of female biology.
The barriers to AI adoption
One of the key conclusions was that the primary barrier to AI adoption in healthcare is not technological capability but acceptance. The challenge lies in whether the system will actually be used in practice.
Healthcare organizations question whether clinicians will trust algorithmic recommendations, whether patients will believe the results and whether existing workflows can realistically change. The sector is inherently risk-averse and operates within strict regulatory oversight, so implementation requires more than technical performance — it requires confidence.
A related structural issue concerns the historical design of medical standards. Many diagnostic frameworks and clinical studies were developed primarily around male physiology. This has contributed to underrecognized symptoms in women, frequent misdiagnosis and gaps in patient education. Even diagnostic devices are now being redesigned to better account for female anatomy, hormonal variability and gender-specific health patterns.
Adoption patterns also vary significantly by region. In the United States and Europe, implementation is driven largely by regulation, validation and clinical evidence requirements. In other markets, the main barriers are accessibility and trust, while some countries introduce AI through top-down policy-driven initiatives.
The implication is that successful implementation depends not only on deploying AI but on integrating it into clinical workflows, regulatory processes and communication with both clinicians and patients.
